Correlation Between Arvinas and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arvinas and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arvinas and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arvinas and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Arvinas and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arvinas with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arvinas and Madrigal Pharmaceuticals.
Diversification Opportunities for Arvinas and Madrigal Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Arvinas and Madrigal is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Arvinas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arvinas are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Arvinas i.e., Arvinas and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arvinas and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Arvinas is expected to generate 34.06 times less return on investment than Madrigal Pharmaceuticals. But when comparing it to its historical volatility, Arvinas is 1.37 times less risky than Madrigal Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 25,079 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 9,439 from holding Madrigal Pharmaceuticals or generate 37.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arvinas vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Arvinas |
| Madrigal Pharmaceuticals |
Arvinas and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arvinas and Madrigal Pharmaceuticals
The main advantage of trading using opposite Arvinas and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arvinas position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals | Madrigal Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |